Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03909789 · ClinicalTrials.gov registry record · NA

Effect of Inorganic Nitrate Supplement on Blood Pressure

A NA study of Blood Pressure and Endothelial Dysfunction, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.

Completed
Registry status
NA
Development phase
67
Enrollment target
1
Study location

NCT03909789 is a NA study of Blood Pressure and Endothelial Dysfunction that has completed, run by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The registered enrollment target is 67 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03909789, a NA study of Blood Pressure and Endothelial Dysfunction, has completed, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.

COMPLETED
Registry status
NA
Development phase
67 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this project is to assess the efficacy (effectiveness) of plant-based nitrate tablets to elevate nitric oxide in your system as measured by saliva and effect on lowering blood pressure (BP), supporting blood vessel function in men and women with hypertension.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Plant based bioequivalent Nitrate supplementation

Study Locations (1)

California

  • Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center - Torrance

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2017-11-17
Est. Completion 2018-06-22
Phase NA

What the Registry Record Tells You About NCT03909789

The ClinicalTrials.gov registry entry for NCT03909789 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (77% lower). The listed sponsor is Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03909789 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03909789 about?

NCT03909789 is a clinical study titled "Effect of Inorganic Nitrate Supplement on Blood Pressure". The primary purpose of this project is to assess the efficacy (effectiveness) of plant-based nitrate tablets to elevate nitric oxide in your system as measured by saliva and effect on lowering blood pressure (BP), supporting blood vessel function in men and women with hypertension.

What is the current status of trial NCT03909789?

This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2017-11-17. Estimated completion is 2018-06-22.

What conditions does trial NCT03909789 study?

This clinical trial studies the following conditions: Blood Pressure, Endothelial Dysfunction.

What interventions are being tested in trial NCT03909789?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Plant based bioequivalent Nitrate supplementation (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03909789?

This trial is sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03909789 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.